LONDON BROKER RATINGS: Whitbread raised; Segro, Oxford BioMedica cut
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 380.60p on 21-08-2026 at 18:35:07 |
|---|---|
| Change | 1.60p 0.42% |
| Buy | 382.40p |
| Sell | 381.60p |
| Last Trade: | Buy 1.00 at 380.60p |
| Day's Volume: | 344,535 |
| Last Close: | 380.60p |
| Open: | 378.20p |
| ISIN: | GB00B82YXW83 |
| Day's Range | 378.00p - 382.60p |
| 52wk Range: | 350.20p - 507.50p |
| Market Capitalisation: | £937.03m |
| VWAP: | 380.6105p |
| Shares in Issue: | 246.20m |
Vesuvius (VSVS) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1 | 380.60p | SI Trade |
16:35:06 - 21-Aug-26 |
| Buy* | 30 | 380.60p | SI Trade |
16:35:06 - 21-Aug-26 |
| Buy* | 1 | 380.60p | SI Trade |
16:35:06 - 21-Aug-26 |
| Buy* | 2,692 | 380.60p | SI Trade |
16:35:06 - 21-Aug-26 |
| Buy* | 2 | 380.60p | SI Trade |
16:35:06 - 21-Aug-26 |
| Buy* | 1,752 | 380.60p | SI Trade |
16:35:06 - 21-Aug-26 |
| Buy* | 201,001 | 380.60p | Suspected BUY Trade |
16:35:06 - 21-Aug-26 |
| Sell* | 28 | 381.60p | Automatic Execution |
16:29:52 - 21-Aug-26 |
| Sell* | 4 | 381.60p | Automatic Execution |
16:29:52 - 21-Aug-26 |
| Buy* | 177 | 382.00p | Automatic Execution |
16:29:39 - 21-Aug-26 |
Vesuvius (VSVS) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 31st Jul 2026 4:48 pm | PRN | Director/PDMR Shareholding |
| 30th Jul 2026 7:00 am | RNS | Half-year Financial Results |
| 27th Jul 2026 7:00 am | RNS | Trading Statement |
| 8th Jul 2026 6:12 pm | PRN | Director/PDMR Shareholding |
| 29th May 2026 5:11 pm | PRN | Directorate change - interim Remuneration Committee Chair |
| 28th May 2026 4:09 pm | PRN | Notice of Results |
| 28th May 2026 7:00 am | PRN | Trading statement |
| 1st May 2026 10:40 am | PRN | Total Voting Rights |
| 14th Apr 2026 6:21 pm | PRN | Director/PDMR Shareholding |
| 14th Apr 2026 6:19 pm | PRN | Director/PDMR Shareholding |